We will take a look at the past year in health care finance and discuss what is on the horizon for next year. We will highlight the trends and activities from 2015 that we anticipate will continue to affect health care providers, including implementation of IRS regulations, mergers, acquisitions, other combinations, and SEC enforcement actions.
Key Takeaways
- Health care provider combinations and emerging structure trends
- The Massachusetts ban on a proposed combination due to perceived cost containment issues
- The evolution of the direct placement market Lessons learned from first rounds of SEC MCDC settlement actions
- Evolution of market conditions
- Living with regulations such as 501(r) and the new allocation and accounting rules
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.